Colinz Laboratories Share Price

Colinz Laboratories

CMP as on17-May-22 14:40

₹ 29.00
0.95 3.39%

Open

₹ 28.10

Turnover (lac)

₹ 1

Prev. Close

₹ 28.05

Day's Vol (shares)

₹ 3,006

Day's Range

₹ 26.65
₹ 29.20

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 01-Apr-2022 - -
Inter alia to consider and approve forfeiture of partly paid up equity shares of the Company on which the call money is pending as on 1st April,2022 for which Final Demand cum Forfeiture Notice was sent by speed post to all such partly paid shareholders vide Company letter dated 1st March, 2022 and published in newspapers on 4th March, 2022. NOTICE is hereby given that the Board of directors of the company at their meeting held on 15th April 2022 have forfeited 20,51,900 partly paid Equity Shares of Rs. 10 each on account of non-payment of Allotment amount due from the concerned shareholders. A list of shareholders with details, whose equity shares have been forfeited is placed on website of the Company i.e. www.findoc-cll.in (WWW.FINDOC-CLL.IN). Public are advised to take note of the same and not to transact on any partly paid up shares of the Company. The shareholders who hold partly paid equity shares have been requested to return the Original share certificates to the Company for cancellation. The Company has already cancelled all such equity shares after forfeiture. If anybody transact in those forfeited shares, the Company shall not be responsible to such transactions (As Per BSE Announcement dated on 15.04.2022)
Board Meeting - 18-Feb-2022 - -
COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/02/2022 inter alia to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company pursuant to Regulation 29(2) of SEBI (LODR) Regulations 2015 is scheduled to be held on Monday 28th February 2022 at the registered office of the Company at A-101 Pratik Industrial Estate Mulund Goregaon Link Road Mumbai Maharashtra 400078 at 3.30 p.m. inter alia to consider and approve forfeiture of partly paid up equity shares of the Company on which the call money is still pending receipt even after several reminders; after giving a final reminder to such shareholders and following the prescribed procedure.
Board Meeting - 12-Jan-2022 - -
COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2022 inter alia to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company pursuant to Regulation 29(2) of SEBI (LODR) Regulations 2015 is scheduled to be held on Monday 31st January 2022 at the registered office of the Company at A-101 Pratik Industrial Estate Mulund Goregaon Link Road Mumbai Maharashtra 400078 at 3.30 p.m. inter-alia to consider approve and take on record the Un- Audited Financial Results (IND-AS) of the Company for the quarter and nine months ended 31st December2021. We would like to inform you that, the Board of Directors of the Company at their meeting held today i.e. 31st January, 2022 has, inter alia considered and approved Unaudited Financial Results (as per IND-AS) for the quarter and nine-months ended on 31st December, 2021. Enclosed herewith a copy of the same along with a copy of Limited Review Report dated 31st January, 2022 received from Vora & Associates, Chartered Accountants, Statutory Auditors of the Company with respect to Unaudited Financial Results for the quarter and nine-months ended on 31st December, 2021. (As per BSE Announcement Dated on 31/01/2022)
Board Meeting - 14-Oct-2021 - -
Quarterly Results COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2021 ,inter alia, to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company, pursuant to Regulation 29(2) & 33 of SEBI (LODR) Regulations, 2015, is scheduled to be held on 30th October, 2021 at 03.30 P.M. at the registered office of the Company at A-101, Pratik Industrial Estate, Mulund-Goregaon Link Road ,Mumbai ,Maharashtra ,400078 inter-alia to consider, approve and take on record the Un-audited Financial Results of the Company for the quarter and half year ended 30th September,2021.
Board Meeting - 14-Jul-2021 - -
COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2021 ,inter alia, to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company, pursuant to Regulation 29(2) of SEBI (LODR) Regulations, 2015, is scheduled to be held on Friday, 14th August, 2020 at the registered office of the Company at A-101, Pratik Industrial Estate, Mulund Goregaon Link Road, Mumbai, Maharashtra - 400078 inter-alia. The Meeting of Board of Directors was held on Friday, 30th July, 2021 at 03:30 p.m. The Board of Directors discussed and/or approved the following: 1. The Board considered and approved Un-Audited Financial Results for the quarter ended 30th June, 2021 as per Regulation 33 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In this regard, the Statutory Auditors have carried out Limited Review of the above results. Please find enclosed copy of unaudited financial results along with Limited Review Report for the quarter ended 30th June, 2021. The Meeting of Board of Directors was held on Friday, 30th July, 2021 at 03:30 p.m. The Board of Directors discussed and/or approved the following: 1. The Board considered and approved Un-Audited Financial Results for the quarter ended 30th June, 2021 as per Regulation 33 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In this regard, the Statutory Auditors have carried out Limited Review of the above results. Please find enclosed copy of unaudited financial results along with Limited Review Report for the quarter ended 30th June, 2021. (As Per BSE Announcement Dated on 30.07.2021)
Board Meeting - 07-May-2021 - -
COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2021 ,inter alia, to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company, pursuant to Regulation 29(2) of SEBI (LODR) Regulations, 2015, is scheduled to be held on Thursday, 27th May, 2021 at the registered office of the Company at A-101, Pratik Industrial Estate, Mulund ink Road, Mumbai, Maharashtra, 400078, at 3.30 p.m. inter-alia to consider, approve and take on record the Audited Financial Results of the Company for the quarter and year ended 31st March, 2021. In terms of provisions of Regulation 30 (read with Part A of Schedule III) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), this is to inform you that the Board of Directors, at its Meeting held today, i.e., 27th May, 2021, has inter alia transacted the following business items : In accordance with Regulation 33 of the Listing Regulations: a. The Board has discussed and approved Annual Audited Standalone Financial Results of the Company prepared as per Indian Accounting Standard (IND- AS) along with Auditors Report thereon and Statement of Assets and Liabilities, for the quarter and financial year ended 31st March 2021 together with the Audit Reports with unmodified opinion(s) in respect of Standalone Financial Results, as submitted by the Auditors of the Company. b. Declaration duly certified by the Chief Financial Officer of the Company to the effect that Auditors have submitted their Report with unmodified opinion. (As per BSE Announcement Dated on 27/05/2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity